Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Mismatch Repair

Mismatch Repair

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine·2026

Same author

Probability Distribution for Rare Neutral Mutations in Cancers and Application to Dynamic Precision Medicine of Cancer.

bioRxiv : the preprint server for biology·2025

Same author

Insights on Clinical Development of Cell and Gene Therapy for Rare Diseases-by DahShu Innovative Design Scientific Working Group (IDSWG).

Therapeutic innovation & regulatory science·2025

Same author

A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer.

medRxiv : the preprint server for health sciences·2025

Same author

Personalized cancer treatment strategies incorporating irreversible and reversible drug resistance mechanisms.

NPJ systems biology and applications·2025

Same author

Integrating Sustainability Pillars Into Trial Design Decision-Making: Results of an International Survey.

Clinical and translational science·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Cancers exhibit a mutator phenotype: clinical implications.

Lawrence A Loeb¹, Jason H Bielas, Robert A Beckman

¹Department of Pathology, University of Washington School of Medicine, Seattle, Washington, USA. larryloeb@earthlink.net

Cancer Research

|May 17, 2008

Summary

This summary is machine-generated.

Cancer cells exhibit a mutator phenotype, a significantly increased mutation rate compared to normal cells. This heightened mutation rate accelerates cancer development and has critical implications for treatment resistance and prognosis.

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jul 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Area of Science:

Genetics
Oncology
Molecular Biology

Background:

Malignancies are characterized by numerous genetic mutations.
Normal human cells exhibit low mutation rates.
Cancer cells are hypothesized to possess a mutator phenotype, with significantly higher mutation rates.

Purpose of the Study:

To investigate the mutator phenotype hypothesis in human cancers.
To explore the origins and implications of increased mutation rates in cancer cells.
To examine the role of genetic instability in carcinogenesis.

Main Methods:

Analysis of mutation rates in cancer cells versus normal cells.
Review of experimental evidence on mutation patterns in human tumors.
Consideration of genetic stability gene mutations as a cause for the mutator phenotype.

Main Results:

Human tumors exhibit a vast array of both clonal and nonexpanded (random) mutations.
A mutator phenotype enhances the acquisition of cancer-associated mutations.
Mutations in genes governing genetic stability may drive the mutator phenotype.

Conclusions:

The mutator phenotype is a key driver of carcinogenesis.
Nonexpanded mutations in tumors have significant clinical implications for risk assessment, grading, and prognosis.
Targeting mutator pathways may offer novel strategies for cancer prevention and treatment delay.